India's Pharmacovigilance Revolution: A Call to Action
India emerges as a global leader in reporting adverse drug events, thanks to its robust pharmacovigilance framework. The 5th National Pharmacovigilance Week, led by the Indian Pharmacopoeia Commission, encourages active reporting from healthcare professionals and patients, with new initiatives to enhance public awareness and digital accessibility.

- Country:
- India
India has positioned itself as a global leader in reporting adverse drug events, according to the Drugs Controller General of India, Dr. Rajeev Raghuvanshi, during a recent event. This accomplishment underscores the growing importance of pharmacovigilance in safeguarding public health.
The Indian Pharmacopoeia Commission, serving as the National Coordination Centre for the Pharmacovigilance Programme of India, launched the 5th National Pharmacovigilance Week at the Bharat Mandapam Convention Centre. Taking place from September 17 to September 23, the theme is 'Your Safety, Just a Click Away: Report to PvPI'.
During the week-long campaign, stakeholders including healthcare professionals, regulators, researchers, and the public are urged to report adverse drug reactions through simplified digital platforms. Initiatives unveiled include a short film, a multi-language pharmacovigilance comic, and a new online reporting platform with QR code access to bolster awareness and participation.
ALSO READ
World Patient Safety Day 2025: WHO Calls for Urgent Action on Child Health Safety
Healthcare Horror in West Bengal: Safety Concerns for Hospital Workers
Mamata Banerjee Highlights Inclusivity in West Bengal's Healthcare Revolution
Delhi's Healthcare Transformation: Ayushman Aarogya Mandir Initiative
Senator Rasha Kelej Received Kenya First Lady at the 7th Edition of Merck Foundation First Ladies Initiative Summit to Discuss Their Joint Programs to Build Healthcare Capacity